US 10391095
DNA-PK inhibitors
granted A61KA61K31/506A61K31/53
Quick answer
US patent 10391095 (DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/506, A61K31/53, A61K31/5377, A61K41/0038